Lord Abbett Micro Cap Growth Fund Class A
Lord Abbett Micro Cap Growth Fund Class A (LAMGX)
The Lord Abbett Micro Cap Growth Fund Class A (LAMGX) is a mutual fund that focuses on investing in small and emerging companies with strong growth potential. This fund aims to provide long-term capital appreciation by investing in a diversified portfolio of micro-cap stocks. Managed by Lord Abbett, a leading investment management firm, this fund offers investors the opportunity to participate in the growth potential of smaller companies while also providing professional management and risk management strategies. With a focus on growth-oriented investments, LAMGX may be suitable for investors seeking higher potential returns and are willing to take on a higher level of risk.
LAMGX Mutual Fund Chart & Stats
- Previous Close
- $21.66
- Sub-Category
- Small Cap
- Total Liabilities
- $5.07M
- Expense Ratio
- 1.37%
- Holding Count
- 84
- Brand
- Lord Abbett Securities Trust
- Category
- Equity
- Total Assets
- 218.08M
- Shares Outstanding
- N/A
- 52-Week Range
- $18.48 - $28.01
LAMGX Mutual Fund News
Enliven Therapeutics’ Strong Q3 Results and Cash Runway Support Buy Rating; Price Target Unchanged at $73
Enliven Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on the stock and has a
LAMGX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| COGTCogent Biosciences, Inc. | 2.75% |
| FBRXForte Biosciences Inc | 2.65% |
| ADPTAdaptive Biotechnologies | 2.62% |
| AEHRAehr Test | 2.60% |
| NAVNNavan, Inc. Class A | 2.54% |
| ELVNEnliven Therapeutics, Inc. | 2.34% |
| LINDLindblad Expeditions Holdings | 2.12% |
| USD_CASHFidelity Investments | 2.03% |
| CECOCeco Environmental Corp. | 1.99% |
| TXG10X Genomics | 1.98% |
| Total | 23.61% |
Recently Viewed
No data currently available






